Patients with fever treated with rAM
|
Control
|
9,231
|
2180 (24%)
|
0
|
0
| |
HW
|
9,752
|
1700 (17%)
|
0.07 (0.004, 0.13)
|
0.03 (−0.04, 0.10)
|
0.44
|
HWP
|
7,887
|
1304 (16%)
|
0.07 (0.01, 0.14)
|
0.05 (−0.002, 0.10)
|
0.06
|
Patients with no fever treated with rAM
|
Control
|
4,863
|
82 (2%)
|
0
|
0
| |
HW
|
6,062
|
193 (3%)
|
−0.003 (−0.02, 0.01)
|
0.002 (−0.01, 0.01)
|
0.52
|
HWP
|
5,984
|
40 (1%)
|
0.01 (−0.01, 0.03)
|
0.002 (−0.01, 0.01)
|
0.73
|
RDT uptake
|
Patients with fever tested with RDT
|
Control
|
9,297
|
4960 (53%)
|
0
|
0
| |
HW
|
9,825
|
5374 (55%)
|
−0.04 (−0.15, 0.07)
|
−0.04 (−0.20, 0.10)
|
0.57
|
HWP
|
7,963
|
5153 (65%)
|
−0.12 (−0.21, −0.03)
|
−0.02 (−0.13, 0.09)
|
0.72
|
RDT eligible (fever and no obvious alternate diagnosis) not tested
|
Control
|
8,241
|
3697 (45%)
|
0
|
0
| |
HW
|
9,064
|
4000 (44%)
|
0.04 (−0.07, 0.15)
|
0.06 (−0.11, 0.23)
|
0.44
|
HWP
|
7,292
|
2459 (34%)
|
0.12 (0.04, 0.21)
|
0.18 (0.05, 0.32)
|
0.01
|
RDT ineligible (no fever) tested
|
Control
|
4,874
|
587 (12%)
|
0
|
0
| |
|
HW
|
6,083
|
955 (16%)
|
−0.01 (−0.07, 0.04)
|
0.01 (−0.06, 0.07)
|
0.86
|
|
HWP
|
6,000
|
518 (9%)
|
0.02 (−0.05, 0.09)
|
0.02 (−0.04, 0.09)
|
0.43
|
Presumptive treatment
|
RDT eligible treated presumptively for malaria
|
Control
|
8,241
|
471 (6%)
|
0
|
0
| |
HW
|
9,064
|
374 (4%)
|
0.02 (−0.01, 0.05)
|
0.01 (−0.02, 0.04)
|
0.40
|
HWP
|
7,292
|
256 (4%)
|
0.02 (−0.003, 0.05)
|
0.02 (−0.004, 0.05)
|
0.09
|
RDT ineligible treated presumptively for malaria
|
Control
|
4,874
|
42 (1%)
|
0
|
0
| |
HW
|
6,083
|
47 (1%)
|
0.004 (−0.001, 0.01)
|
0.003 (−0.001, 0.01)
|
0.15
|
HWP
|
6,000
|
12 (0.2%)
|
0.007 (0.003, 0.01)
|
0.004 (−0.0001, 0.01)
|
0.05
|
Adherence to RDT negative
|
RDT negative receiving AM
|
Control
|
4,015
|
762 (19%)
|
0
|
0
| |
HW
|
4,539
|
250 (6%)
|
0.14 (0.08, 0.20)
|
0.10 (0.03, 0.17)
|
0.01
|
HWP
|
4,330
|
189 (4%)
|
0.15 (0.09, 0.21)
|
0.10 (0.04, 0.16)
|
0.002
|
RDT negative receiving AM (among those with fever)
|
Control
|
3,488
|
723 (21%)
|
0
|
0
| |
HW
|
3,793
|
235 (6%)
|
0.16 (0.08, 0.23)
|
0.11 (0.03, 0.19)
|
0.01
|
HWP
|
3,897
|
177 (5%)
|
0.21 (0.04, 0.17)
|
0.12 (0.05, 0.19)
|
0.002
|
RDT negative receiving AM (among those with no fever)
|
Control
|
527
|
39 (7%)
|
0
|
0
| |
HW
|
746
|
15 (2%)
|
0.05 (−0.01, 0.10)
|
0.03 (0.01 0.05)
|
0.004
|
HWP
|
433
|
12 (3%)
|
0.04 (−0.01, 0.10)
|
-
|
-
|
Adherence to RDT positive
|
RDT positive receiving rAM
|
Control
|
1,455
|
1166 (80%)
|
0
|
0
| |
|
HW
|
1,696
|
1402 (83%)
|
−0.10 (−0.35, 0.15)
|
−0.13 (−0.45, 0.19)
|
0.39
|
|
HWP
|
1,249
|
963 (77%)
|
−0.17 (−0.41, 0.06)
|
−0.04 (−0.25, 0.17)
|
0.69
|
RDT positive receiving rAM (among those with fever)
|
Control
|
1,406
|
1149 (82%)
|
0
|
0
| |
HW
|
1,508
|
1255 (83%)
|
−0.07 (−0.31, 0.18)
|
−0.11 (−0.44, 0.22)
|
0.49
|
HWP
|
1,180
|
942 (79%)
|
−0.14 (−0.37, 0.09)
|
−0.01 (−0.23, 0.21)
|
0.89
|
RDT positive receiving rAM (among those without fever)
|
Control
|
49
|
17 (35%)
| | | |
HW
|
188
|
147 (78%)
|
-
|
-
| |
HWP
|
69
|
21 (30%)
|
-
|
-
| |
Treatment with antibiotics
|
Non-malarial illness receiving ABx
|
Control
|
8,942
|
6865 (77%)
|
0
|
0
| |
HW
|
10,118
|
7886 (78%)
|
0.01 (−0.09, 0.12)
|
0.02 (−0.22, 0.24)
|
0.89
|
HWP
|
10,163
|
7525 (74%)
|
0.01 (−0.04, 0.07)
|
0.14 (−0.01, 0.29)
|
0.06
|
RDT negative receiving ABx
|
Control
|
4,015
|
2977 (74%)
|
0
|
0
| |
HW
|
4,539
|
3527 (78%)
|
−0.02 (−0.12, 0.09)
|
0.003 (−0.23, 0.24)
|
0.98
|
HWP
|
4,330
|
3236 (75%)
|
−0.004 (−0.07, 0.06)
|
0.13 (−0.02, 0.27)
|
0.08
|
RDT eligible receiving ABx
|
Control
|
8,241
|
5731 (70%)
|
0
|
0
| |
HW
|
9,064
|
6808 (75%)
|
−0.03 (−0.13, 0.07)
|
0.01 (−0.21, 0.25)
|
0.89
|
HWP
|
7,292
|
4,994 (68%)
|
0.01 (−0.09, 0.10)
|
0.13 (−0.03, 0.30)
|
0.09
|
RDT ineligible receiving ABx
|
Control
|
4,863
|
3774 (78%)
|
0
|
0
| |
HW
|
6,062
|
4531 (75%)
|
0.07 (−0.07, 0.20)
|
0.03 (−0.21, 0.28)
|
0.77
|
HWP
|
5,984
|
4334 (72%)
|
0.04 (−0.02, 0.10)
|
0.15 (0.01, 0.30)
|
0.04
|